干细胞。培养皿中的疾病研究取得进展。 - Suppr

Suppr

超能文献

Stem cells. Diseases in a dish take off.

作者信息

Vogel Gretchen

出版信息

Science. 2010 Nov 26;330(6008):1172-3. doi: 10.1126/science.330.6008.1172.

DOI:10.1126/science.330.6008.1172

PMID:21109645

Abstract

摘要

相似文献

Stem cells. Diseases in a dish take off.

Science. 2010 Nov 26;330(6008):1172-3. doi: 10.1126/science.330.6008.1172.

iPSC technology: platform for drug discovery. Point.

Clin Pharmacol Ther. 2011 May;89(5):639-41. doi: 10.1038/clpt.2011.22.

The use of induced pluripotent stem cells in drug development.

Clin Pharmacol Ther. 2011 May;89(5):655-61. doi: 10.1038/clpt.2011.38. Epub 2011 Mar 23.

The use of human embryonic stem cells in drug discovery. Counterpoint.

Clin Pharmacol Ther. 2011 May;89(5):641-3. doi: 10.1038/clpt.2011.19.

Human stem cells for modeling neurological disorders: accelerating the drug discovery pipeline.

J Cell Biochem. 2008 Dec 15;105(6):1361-6. doi: 10.1002/jcb.21967.

Human induced pluripotent stem cells: the past, present, and future.

Clin Pharmacol Ther. 2011 May;89(5):741-5. doi: 10.1038/clpt.2011.37. Epub 2011 Mar 23.

Drug screening for human genetic diseases using iPSC models.

Hum Mol Genet. 2018 Aug 1;27(R2):R89-R98. doi: 10.1093/hmg/ddy186.

Labeled stem cells as disease models and in drug discovery.

Methods Mol Biol. 2013;997:239-51. doi: 10.1007/978-1-62703-348-0_19.

An introduction to induced pluripotent stem cells.

Br J Haematol. 2010 Oct;151(1):16-24. doi: 10.1111/j.1365-2141.2010.08296.x. Epub 2010 Jul 27.

iPS cell derived neuronal cells for drug discovery.

Trends Pharmacol Sci. 2014 Oct;35(10):510-9. doi: 10.1016/j.tips.2014.07.003. Epub 2014 Aug 3.

引用本文的文献

In Vitro Models for Improved Therapeutic Interventions in Atrial Fibrillation.

J Pers Med. 2023 Aug 8;13(8):1237. doi: 10.3390/jpm13081237.

Gene editing with 'pencil' rather than 'scissors' in human pluripotent stem cells.

Stem Cell Res Ther. 2023 Jun 20;14(1):164. doi: 10.1186/s13287-023-03394-5.

α-synuclein pathogenesis in hiPSC models of Parkinson's disease.

Neuronal Signal. 2021 Jun 23;5(2):NS20210021. doi: 10.1042/NS20210021. eCollection 2021 Jun.

Current progress of skin tissue engineering: Seed cells, bioscaffolds, and construction strategies.

Burns Trauma. 2013 Sep 18;1(2):63-72. doi: 10.4103/2321-3868.118928. eCollection 2013.

Tapping Stem Cells to Target AMD: Challenges and Prospects.

J Clin Med. 2015 Jan 29;4(2):282-303. doi: 10.3390/jcm4020282.

PRP treatment effects on degenerative tendinopathy - an in vitro model study.

Muscles Ligaments Tendons J. 2014 May 8;4(1):10-7. eCollection 2014 Jan.

A stochastic model dissects cell states in biological transition processes.

Sci Rep. 2014 Jan 17;4:3692. doi: 10.1038/srep03692.

Induced pluripotent stem cells: the new patient?

Nat Rev Mol Cell Biol. 2012 Nov;13(11):713-26. doi: 10.1038/nrm3448. Epub 2012 Oct 4.

Induced pluripotent stem cells and personalized medicine: current progress and future perspectives.

Anat Cell Biol. 2011 Dec;44(4):245-55. doi: 10.5115/acb.2011.44.4.245. Epub 2011 Dec 30.

Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations.

Cell. 2011 Jul 22;146(2):318-31. doi: 10.1016/j.cell.2011.06.019. Epub 2011 Jul 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Stem cells. Diseases in a dish take off.

Science. 2010 Nov 26;330(6008):1172-3. doi: 10.1126/science.330.6008.1172.

iPSC technology: platform for drug discovery. Point.

Clin Pharmacol Ther. 2011 May;89(5):639-41. doi: 10.1038/clpt.2011.22.

The use of induced pluripotent stem cells in drug development.

Clin Pharmacol Ther. 2011 May;89(5):655-61. doi: 10.1038/clpt.2011.38. Epub 2011 Mar 23.

The use of human embryonic stem cells in drug discovery. Counterpoint.

Clin Pharmacol Ther. 2011 May;89(5):641-3. doi: 10.1038/clpt.2011.19.

Human stem cells for modeling neurological disorders: accelerating the drug discovery pipeline.

J Cell Biochem. 2008 Dec 15;105(6):1361-6. doi: 10.1002/jcb.21967.

Human induced pluripotent stem cells: the past, present, and future.

Clin Pharmacol Ther. 2011 May;89(5):741-5. doi: 10.1038/clpt.2011.37. Epub 2011 Mar 23.

Drug screening for human genetic diseases using iPSC models.

Hum Mol Genet. 2018 Aug 1;27(R2):R89-R98. doi: 10.1093/hmg/ddy186.

Labeled stem cells as disease models and in drug discovery.

Methods Mol Biol. 2013;997:239-51. doi: 10.1007/978-1-62703-348-0_19.

An introduction to induced pluripotent stem cells.

Br J Haematol. 2010 Oct;151(1):16-24. doi: 10.1111/j.1365-2141.2010.08296.x. Epub 2010 Jul 27.

iPS cell derived neuronal cells for drug discovery.

Trends Pharmacol Sci. 2014 Oct;35(10):510-9. doi: 10.1016/j.tips.2014.07.003. Epub 2014 Aug 3.

引用本文的文献

In Vitro Models for Improved Therapeutic Interventions in Atrial Fibrillation.

J Pers Med. 2023 Aug 8;13(8):1237. doi: 10.3390/jpm13081237.

Gene editing with 'pencil' rather than 'scissors' in human pluripotent stem cells.

Stem Cell Res Ther. 2023 Jun 20;14(1):164. doi: 10.1186/s13287-023-03394-5.

α-synuclein pathogenesis in hiPSC models of Parkinson's disease.

Neuronal Signal. 2021 Jun 23;5(2):NS20210021. doi: 10.1042/NS20210021. eCollection 2021 Jun.

Current progress of skin tissue engineering: Seed cells, bioscaffolds, and construction strategies.

Burns Trauma. 2013 Sep 18;1(2):63-72. doi: 10.4103/2321-3868.118928. eCollection 2013.

Tapping Stem Cells to Target AMD: Challenges and Prospects.

J Clin Med. 2015 Jan 29;4(2):282-303. doi: 10.3390/jcm4020282.

PRP treatment effects on degenerative tendinopathy - an in vitro model study.

Muscles Ligaments Tendons J. 2014 May 8;4(1):10-7. eCollection 2014 Jan.

A stochastic model dissects cell states in biological transition processes.

Sci Rep. 2014 Jan 17;4:3692. doi: 10.1038/srep03692.

Induced pluripotent stem cells: the new patient?

Nat Rev Mol Cell Biol. 2012 Nov;13(11):713-26. doi: 10.1038/nrm3448. Epub 2012 Oct 4.

Induced pluripotent stem cells and personalized medicine: current progress and future perspectives.

Anat Cell Biol. 2011 Dec;44(4):245-55. doi: 10.5115/acb.2011.44.4.245. Epub 2011 Dec 30.

Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations.

Cell. 2011 Jul 22;146(2):318-31. doi: 10.1016/j.cell.2011.06.019. Epub 2011 Jul 14.